Hernia

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

Retrieved on: 
Thursday, March 21, 2024
Growth, Partnership, Anatomy, Webcast, Travel, PRS, Matrix, Sale, Hernia, MiMedx, Event, FDA, Video game

“The recalibration of our sales force over 2023 has led to increased productivity and an improved mix of sales across our product portfolio.

Key Points: 
  • “The recalibration of our sales force over 2023 has led to increased productivity and an improved mix of sales across our product portfolio.
  • 2023 was a great year that sets TELA Bio up for even more achievement in 2024!”
    Revenue was $17.0 million in the fourth quarter of 2023, an increase of 46% compared to the same period in 2022.
  • Operating expenses were $23.9 million in the fourth quarter of 2023, compared to $17.6 million in the same period in 2022.
  • TELA Bio will host a conference call at 4:30 p.m. Eastern Time on Thursday, March 21, 2024 to discuss its fourth quarter and full year 2023 financial results.

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

Retrieved on: 
Wednesday, March 20, 2024
Burn, Patient, Matrix, Sale, Hernia, Human, Surgeon, Wound healing

MALVERN, Pa., March 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc .

Key Points: 
  • MALVERN, Pa., March 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc .
  • (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the sale of its distribution rights related to NIVIS Fibrillar Collagen Pack to Atlanta-based MiMedx Group, Inc. (“MIMEDX”).
  • NIVIS is an absorbent collagen matrix indicated for the management of moderately to heavily exudating wounds and to control minor bleeding.
  • MIMEDX is a pioneer and leader focused on helping humans heal, with a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare.

Whether it's Winter Storms or Hurricanes, Animal Rescuers Race to Save Dogs in Danger

Retrieved on: 
Wednesday, January 24, 2024
Storm, Weather, FUR, Animal, Hernia, Dog, Freezing, Risk, Safety, Friends

JACKSONVILLE, Fla., Jan. 24, 2024 /PRNewswire/ -- A five month old puppy was kicked out into the winter weather as sub-freezing temperatures swept across the country. When she went to another house looking for help, they literally kicked her down the stairs. A neighbor saw what happened and reached out to Florida Urgent Rescue (FUR) for help. 

Key Points: 
  • JACKSONVILLE, Fla., Jan. 24, 2024 /PRNewswire/ -- A five month old puppy was kicked out into the winter weather as sub-freezing temperatures swept across the country.
  • Florida Urgent Rescue worked with rescue groups throughout the state to help evacuate dogs from outdoor kennels in a rural Union County Shelter.
  • As Winter Storm Heather approached, Pet Paradise once again helped FUR, acting as a temporary way station and boarding the remaining dogs who didn't have a plan.
  • "The problems are the same, whether it's a winter storm, a hurricane or another disaster," said Mike Merrill, Founder and Executive Director of FUR.

New York's Top Hernia and Core Surgeon Mark Zoland M.D. F.A.C.S. Receives Castle Connolly's 2024 Top Doctor® Award

Retrieved on: 
Tuesday, January 23, 2024
Core, Patient, Weill Cornell Medicine, MLB, Pelvic pain, NBA, Multimedia, Knowledge, Castle Connolly Medical, Groin, Medicine, Suite, Hernia, MLS, Columbia University, NFL, NHL, American College

NEW YORK, Jan. 23, 2024 /PRNewswire-PRWeb/ -- Dr. Mark Zoland, a highly esteemed medical professional, has been honored with the prestigious title of 2024 Castle Connolly Top Doctor. This recognition places him among the top 7% of all doctors nationally, highlighting his exceptional skills and dedication to providing outstanding healthcare. Dr. Zoland's nomination by his peers adds an extra layer of significance to this achievement. It is a testament to his exceptional reputation within the medical community, as well as his unwavering commitment to his patients' well-being. For over three decades, Castle Connolly has been the foremost authority in identifying and honoring Top Doctors who consistently deliver exceptional care. As the most trusted source for patients seeking best-in-class healthcare providers, Castle Connolly takes great pride in recognizing medical professionals like Dr. Zoland, who exemplify a longstanding commitment to their patients. Dr. Zoland's impressive educational background includes a bachelor's degree from Columbia University and a medicine degree from Cornell University Medical College in 1993. Since 2001, he has been board-certified and a Fellow of the American College of Surgeons, showcasing his expertise and dedication to his field. Dr. Mark Zoland specializes in surgery for many conditions, including complex hernias and groin injuries. He leads an elite medical team at Core Surgical in New York City. Dr. Zoland offers unparalleled knowledge and experience, providing the highest level of care in areas such as hernia repair, groin pain, pelvic pain, sports-related groin/pelvic injuries and non-surgical treatment recommendations.

Key Points: 
  • NEW YORK, Jan. 23, 2024 /PRNewswire-PRWeb/ -- Dr. Mark Zoland , a highly esteemed medical professional, has been honored with the prestigious title of 2024 Castle Connolly Top Doctor.
  • For over three decades, Castle Connolly has been the foremost authority in identifying and honoring Top Doctors who consistently deliver exceptional care.
  • More about Dr. Mark Zoland and Core Surgical:
    Dr. Mark Zoland and Dr. Joseph Iraci lead the team of pelvic and groin medical professionals at their advanced surgical center in New York City.
  • To schedule a consultation with Dr. Mark Zoland or for more information about Core Surgical, please visit http://www.coresurgicalmd.com or call (212) 628-8771
    View original content to download multimedia: https://www.prweb.com/releases/new-yorks-top-hernia-and-core-surgeon-mar...

TELA Bio to Take Part in Connecting the Dots

Retrieved on: 
Tuesday, December 5, 2023
Perfect Match, Dots, Risk, Anatomy, Connect the dots, Hernia, Surgeon, BBC, Recurrence, Patient, MedTech Europe

MALVERN, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc .

Key Points: 
  • MALVERN, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc .
  • The Connecting the Dots series will include a mini-documentary style film, A Perfect Match, produced for TELA Bio highlighting the use of OviTex® Reinforced Tissue Matrix in hernia repair.
  • Connecting The Dots is a new series of branded films presented by MedTech Europe.
  • “We’re thrilled to take part in this series,” said Antony Koblish, President and CEO of TELA Bio.

The Franche-Comté Polyclinic & Moon Surgical Showcase the Maestro System's Simplicity and Ease-of-Use

Retrieved on: 
Tuesday, December 5, 2023
SAN, Surgeon, Patient, Artificial intelligence, Maestro, Pain, Cholecystectomy, Learning curve, Robotics, Hernia, Dentistry, Nursing

The surgical team at the Franche-Comté Polyclinic rapidly achieved autonomy with the Maestro System, requiring support from Moon Surgical staff for just six procedures before independently managing setup and operation.

Key Points: 
  • The surgical team at the Franche-Comté Polyclinic rapidly achieved autonomy with the Maestro System, requiring support from Moon Surgical staff for just six procedures before independently managing setup and operation.
  • Since then, Maestro has become a central part of our surgical practice."
  • "The Maestro System has been a wonderful addition to our operating room," said Dany Scheffer, who assists Dr. Mercoli at the Franche-Comté Polyclinic.
  • With the Maestro System, Moon Surgical empowers laparoscopy teams in these procedures with the latest technology in robotics, computer vision, and artificial intelligence.

Implantica publishes Interim Report January - September 2023 (Q3)

Retrieved on: 
Wednesday, November 22, 2023
ID, Mary, mother of Jesus, Corporate Affairs, Safety, Food, CFO, Saint Mary's Hospital, GERD, Investment, EFS, Surgeon, Nissen fundoplication, Learning, Vienna General Hospital, Patient, CET, Congress, FDA, ARB, NHS, AFS, Food and Drug Administration, Usability, IPAC, Certification, ISPOR, Health, Hospital, PMA, Hernia, Pharmaceutical industry, Medical device

The Interventional Procedures Advisory Committee (IPAC) has now started its review of the safety and efficacy of RefluxStop™.

Key Points: 
  • The Interventional Procedures Advisory Committee (IPAC) has now started its review of the safety and efficacy of RefluxStop™.
  • The IPAC review process is a key step for NHS hospitals to adopt our technology with strong international influence.
  • Implantica will hold a teleconference on 22 November 2023 at 15:00 (CET) with Peter Forsell (CEO), Andreas Öhrnberg (CFO), and Nicole Pehrsson (Chief Corporate Affairs Officer).
  • The information was submitted for publication, through the agency of the contact person set out above, at 2023-11-22 08:00 CET.

Global Hernia Mesh Devices Market Size, Share & Trends Analysis Report 2023: Market to Reach $8.3 Billion by 2030 - Innovation in Enhancing Patient Outcomes Bolsters Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, October 13, 2023
Medical Supplies, Medical Devices, Health, Surgery, General Health, Biotechnology, Incidence, Femoral hernia, Hernia, Capillary action through synthetic mesh, Prevalence, Inguinal hernia, USD, Biomesh, Growth, Incisional hernia, Operation Time, Patient, Thermoplastic, Pharmaceutical industry

The "Hernia Mesh Devices Market Size, Share & Trends Analysis Report By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia), By Mesh Type (Biologic Mesh, Synthetic Mesh), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hernia Mesh Devices Market Size, Share & Trends Analysis Report By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia), By Mesh Type (Biologic Mesh, Synthetic Mesh), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global hernia mesh devices market size is expected to reach USD 8.3 billion by 2030.
  • Additionally, the market benefits from a favorable reimbursement scenario, which encourages patients to opt for hernia surgeries, further boosting market growth.
  • Among hernia types, inguinal hernia repair devices hold a substantial market share, thanks to the wide range of available mesh products designed specifically for inguinal repair.

CMR Surgical surpasses 15,000 surgical procedures on Versius® globally as it raises $165 million to support continued growth

Retrieved on: 
Wednesday, September 20, 2023
SoftBank Vision Fund, CE, Royal college, Enterprise, Surgeon, Accreditation, Journal of Minimal Access Surgery, Gleneagles Hospital, Lung lobectomy, Royal, Tencent, Innovation, MAS, Royal Papworth Hospital NHS Foundation Trust, Sindh Institute of Urology & Transplantation, Hospital, Patient, Royal Papworth Hospital, SIUT, Hernia, Growth, CMR, CMR Surgical, LGT, News, BST, Dentistry

The company has recently closed an upsized $165 million (£133 million) fundraising to support continued product innovation and commercial growth in existing and key new markets around the world.

Key Points: 
  • The company has recently closed an upsized $165 million (£133 million) fundraising to support continued product innovation and commercial growth in existing and key new markets around the world.
  • CMR Surgical (CMR or ‘the Company’) – the global surgical robotics business – has today announced that its next-generation Versius® Surgical Robotic System has been used to perform more than 15,000 surgeries globally.
  • The surgical cases span more than 130 complex and benign procedure types including colectomies, hernia repairs, hysterectomies, sacrocolpopexies, and lobectomies across seven surgical specialties.
  • CMR’s vision is to make MAS universally accessible, rapidly increasing the number of robotic-assisted procedures that take place globally.

CMR Surgical surpasses 15,000 surgical procedures on Versius® globally as it raises $165 million to support continued growth

Retrieved on: 
Wednesday, September 20, 2023
SoftBank Vision Fund, CE, Royal college, Enterprise, Surgeon, Accreditation, Journal of Minimal Access Surgery, Gleneagles Hospital, Lung lobectomy, Royal, Tencent, Innovation, MAS, Royal Papworth Hospital NHS Foundation Trust, Sindh Institute of Urology & Transplantation, Hospital, Patient, Royal Papworth Hospital, SIUT, Hernia, Growth, CMR, CMR Surgical, LGT, News, BST, Dentistry

The company has recently closed an upsized $165 million (£133 million) fundraising to support continued product innovation and commercial growth in existing and key new markets around the world.

Key Points: 
  • The company has recently closed an upsized $165 million (£133 million) fundraising to support continued product innovation and commercial growth in existing and key new markets around the world.
  • CMR Surgical (CMR or ‘the Company’) – the global surgical robotics business – has today announced that its next-generation Versius® Surgical Robotic System has been used to perform more than 15,000 surgeries globally.
  • The surgical cases span more than 130 complex and benign procedure types including colectomies, hernia repairs, hysterectomies, sacrocolpopexies, and lobectomies across seven surgical specialties.
  • CMR’s vision is to make MAS universally accessible, rapidly increasing the number of robotic-assisted procedures that take place globally.